Curtis Clark
Acute Care · Riverton, UTNPI 1962806786
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $750 of the $840 with a category attached, or 89.3%. It is spread thinly across 14 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations.
Across 33 payments — averaging $25.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$189
- Avadel CNS Pharmaceuticals, LLC$133
- Axsome Therapeutics, Inc.$74
- Inspire Medical Systems, Inc.$70
- Melinta Therapeutics, LLC$52
- AbbVie$51
- plus $269 from 8 others
What the payments were for
- Food & beverage$75089%
- Education$9011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 5 | $189 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $133 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Inspire Medical Systems, Inc. | 3 | $70 |
| Melinta Therapeutics, LLC | 2 | $52 |
| AbbVie | 2 | $51 |
| Integra Lifesciences Corporation | 2 | $51 |
| Viatris Specialty LLC | 2 | $50 |
| Amgen | 1 | $38 |
| Philips North America LLC | 1 | $31 |
| Exeltis, USA Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $29 |
| Mylan Specialty L.p. | 1 | $28 |
| Fisher & Paykel Healthcare Inc | 1 | $14 |
How this compares
$840 in reported general payments places this provider in the 80th percentile of 119 acute care providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 31 | $1,869 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $250 |
Paid to pharmacies, not to this prescriber.
Other acute care in Riverton
- Jan DavisOgden$90K
- Kristina GibsonMurray$82K
- Kali DaytonMidvale$17K
- Evangeline LindorfProvo$8K
- Florin ButucMurray$4K
- Chia-Hsuan LinMurray$3K
- Cory HesterMurray$2K
- Karleena SnowSalt Lake City$2K
- Kristi KissellSalt Lake City$2K
- Anne ClaytonMurray$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.